Back to search
FDAFDA · Food and drugs·Recall number D-1445-2020

Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86

Published August 5, 2020 · Recall initiated: July 6, 2020

Summary

FDA records drug Class III recall D-1445-2020, published August 5, 2020 and initiated July 6, 2020. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 3516 bottles; Lot: Lot #: AA84106, Exp 9/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide USA
Lot
Lot #: AA84106, Exp 9/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86 recalled?

Yes. FDA published recall D-1445-2020 on August 5, 2020. Reported hazard: Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

What should I do if I have this product?

Voluntary: Firm initiated · Letter